Lawsuits Allege Byetta Can Cause Pancreatic Cancer

December 18, 2013

Important Information

ClassAction.org is no longer reviewing claims for this case. The information here is for reference only. Up-to-date information and resources can be found here.

Comments |

At A Glance

This Alert Affects
Patients who developed pancreatic cancer after using Byetta (exenatide).
What Is Byetta?
Byetta is a twice-daily injectable drug used to treat Type 2 diabetes. It belongs to a group of drugs known as incretin mimetics.
Manufacturer
Amylin Pharmaceuticals and former partner company Eli Lilly and Company.
FDA Warning
In 2013, the FDA announced that it would be investigating the safety of incretin mimetics after a study found that these drugs may cause pre-cancerous cellular changes in the pancreas. Previously, the FDA warned that there may be a link between Byetta and pancreatitis (inflammation of the pancreas), which may be a symptom of pancreatic cancer.
Type of Lawsuit
Mass Tort